Literature DB >> 28270557

RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα.

Andrea Varga1, Karin Ehrenreiter1, Bertram Aschenbrenner1, Pawel Kocieniewski2, Marek Kochanczyk2, Tomasz Lipniacki2, Manuela Baccarini3.   

Abstract

Downstream of growth factor receptors and of the guanine triphosphatase (GTPase) RAS, heterodimers of the serine/threonine kinases BRAF and RAF1 are critical upstream kinases and activators of the mitogen-activated protein kinase (MAPK) module containing the mitogen-activated and extracellular signal-regulated kinase kinase (MEK) and their targets, the extracellular signal-regulated kinase (ERK) family. Either direct or scaffold protein-mediated interactions among the components of the ERK module (the MAPKKKs BRAF and RAF1, MEK, and ERK) facilitate signal transmission. RAF1 also has essential functions in the control of tumorigenesis and migration that are mediated through its interaction with the kinase ROKα, an effector of the GTPase RHO and regulator of cytoskeletal rearrangements. We combined mutational and kinetic analysis with mathematical modeling to show that the interaction of RAF1 with ROKα is coordinated with the role of RAF1 in the ERK pathway. We found that the phosphorylated form of RAF1 that interacted with and inhibited ROKα was generated during the interaction of RAF1 with the ERK module. This mechanism adds plasticity to the ERK pathway, enabling signal diversification at the level of both ERK and RAF. Furthermore, by connecting ERK activation with the regulation of ROKα and cytoskeletal rearrangements by RAF1, this mechanism has the potential to precisely coordinate the proper timing of proliferation with changes in cell shape, adhesion, or motility.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28270557     DOI: 10.1126/scisignal.aai8482

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  15 in total

1.  Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.

Authors:  Timothy Travers; Cesar A López; Constance Agamasu; Jeevapani J Hettige; Simon Messing; Angel E García; Andrew G Stephen; S Gnanakaran
Journal:  Biophys J       Date:  2020-06-27       Impact factor: 4.033

2.  RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).

Authors:  Alex J Lee; Elise Fraser; Brittany Flowers; Jee Kim; Kenneth Wong; Christophe Cataisson; Huaitian Liu; Howard Yang; Maxwell P Lee; Stuart H Yuspa; Luowei Li
Journal:  Mol Carcinog       Date:  2021-09-17       Impact factor: 5.139

Review 3.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02

4.  Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling.

Authors:  Oleksii S Rukhlenko; Fahimeh Khorsand; Aleksandar Krstic; Jan Rozanc; Leonidas G Alexopoulos; Nora Rauch; Keesha E Erickson; William S Hlavacek; Richard G Posner; Silvia Gómez-Coca; Edina Rosta; Cheree Fitzgibbon; David Matallanas; Jens Rauch; Walter Kolch; Boris N Kholodenko
Journal:  Cell Syst       Date:  2018-07-11       Impact factor: 10.304

Review 5.  The progress of circular RNAs in various tumors.

Authors:  Dandan Wang; Sujin Yang; Hui Wang; Jinyan Wang; Qian Zhang; Siying Zhou; Yunjie He; Heda Zhang; Fei Deng; Hanzi Xu; Shanliang Zhong; Li Fu; Jinhai Tang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

6.  An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion.

Authors:  Christian Baumgartner; Stefanie Toifl; Matthias Farlik; Florian Halbritter; Ruth Scheicher; Irmgard Fischer; Veronika Sexl; Christoph Bock; Manuela Baccarini
Journal:  Cell Stem Cell       Date:  2018-05-24       Impact factor: 24.633

7.  CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.

Authors:  P Jain; T M Fierst; H J Han; T E Smith; A Vakil; P B Storm; A C Resnick; A J Waanders
Journal:  Oncogene       Date:  2017-08-14       Impact factor: 9.867

8.  A systematic analysis of signaling reactivation and drug resistance.

Authors:  Boris N Kholodenko; Nora Rauch; Walter Kolch; Oleksii S Rukhlenko
Journal:  Cell Rep       Date:  2021-05-25       Impact factor: 9.423

Review 9.  The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction.

Authors:  Olga Soriano; Marta Alcón-Pérez; Miguel Vicente-Manzanares; Esther Castellano
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

Review 10.  The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy.

Authors:  Jimin Yuan; Xiaoduo Dong; Jiajun Yap; Jiancheng Hu
Journal:  J Hematol Oncol       Date:  2020-08-17       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.